Drugs / Sulfamethoxazole/trimethoprim
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02624440 | Jan 2013 → Jul 2016 | infectious disease, plasma cell myeloma | Henrik Gregersen | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulfamethoxazole/trimethoprim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02624440 ↗ |
| Route | Oral | “P.o. sulfamethoxazole/trimethoprim 400/80 mg twice daily” NCT02624440 ↗ |